A Grading Scheme for the Assessment of Proliferative Lesions of the Mouse Prostate in the TRAMP Model

Toxicologic Pathology

Volumn 31, Issue 1, 2003, Pages 31-38

  Suttie, Andrew ^a   Nyska, Abraham ^b   Haseman, Joseph K ^c   Moser, Glenda J ^a   Hackett, Theleria R ^a   Goldsworthy, Thomas L ^a  

^a INTEGRATED LABORATORY SYSTEMS   (United States)

^b Laboratory of Immunobiology   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Grading; histopathology; mouse prostatic cancer; quantitation; TRAMP

Indexed keywords

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCULATION; DISEASE SEVERITY; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE TUMOR; RATING SCALE; SCORING SYSTEM; TRANSGENIC MOUSE;

ADENOCARCINOMA; ANIMALS; CALORIC RESTRICTION; DISEASE MODELS, ANIMAL; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; ORGAN SIZE; PROSTATE; PROSTATIC NEOPLASMS; TIME FACTORS;

ANIMALIA; MUS MUSCULUS;

EID: 12244299830     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1080/01926230390173842     Document Type: Article

References (18)

1. Cotran RS, Kumar V., Collins T. (1999). RobbinsPathologicBasis of Disease. WB Saunders Co, Philadelphia.
2. Demark-Wahnefried W., Price DT, Polascik TJ, Robertson CN, Anderson EE, Paulson DF, Walther PJ, Gannon M., Vollmer RT (2001). Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: Exploring the effects on hormonal levels, prostatespecific antigen, and histopathologic features. Urology 58: 47-52.
3. Eng MH, Charles LG, Ross BD, Chrisp CE, Pienta KJ, Greenberg NM, Hsu CX, Sanda MG (1999). Early castration reduces prostatic carcinogenesis in trangenic mice. Urology 54: 1112-1119.
4. Gingrich JR, Barrios RJ, Foster RJ, Greenberg NM (1999). Pathologic progression of autochthonous prostate cancer in the TRAMP model. Prostate Cancer and Prostatic Diseases 2: 70-75.
5. Gingrich JR, Barrios RJ, Kattan MW, Nahm HS, Finegold MJ, Greenberg NM (1997). Androgen-independent prostate cancer progression in the TRAMP model. Cancer Res 57: 4687-4691.
6. Gingrich JR, Barrios RJ, Morton RA, Boyce BF, DeMayo FJ, Finegold MJ, Angelopoulou R., Rosen JM, Greenberg NM (1996). Metastatic prostate cancer in a transgenic mouse. Cancer Res 56: 4096-4102.
7. Greenberg NM, De Mayo F., Finegold MJ, Medina D., Tilley WD, Aspinal JO, Cunha GR, Donjacour AA, Matusik RJ, Rosen JM (1995). Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 92: 3439-3443.
8. Gupta S., Ahmad N., Marengo SR, MacLennan GT, Greenberg NM, Mukhtar H. (2000). Chemoprevention of prostate carcinogenesis by difluoromethylornithine in TRAMP Mice. Cancer Res 60: 5125-5133.
9. Gupta S., Hastak K., Ahmad N., Lewin JS, Mukhtar H. (2001). Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc Natl Acad Sci USA 98: 10350-10355.
10. Keenan KP, Laroque P., Ballam GC, Soper KA, Dixit R., Mattson BA, Adams SP, Coleman JB (1996). The effects of diet, ad libitum overfeeding, andmoderate dietary restriction on the rodent bioassay: The uncontrolled variable in safety assessment. Toxicol Pathol 24: 757-768.
11. Masumori N., Thomas TZ, Chaurand P., Case T., Paul M., Kasper S., Caprioli RM, Tsukamoto T., Shappell SB, Matusik RJ (2001). A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential. Cancer Res 61: 2239-2249.
12. Nyska A., Suttie A., Lomnitski L., Bakshi S., Grossman S., Bergman M., Ben Shaul V., Crockett P., Haseman JK, Moser G., Goldsworthy T., Maronpot RR (2002). Slowing tumorigenic progression in TRAMP mice and prostatic carcinoma cell lines using natural antioxidant from spinach, NAO—A comparative study of three antioxidants. Toxicol Pathol, 31: 39-51.
13. Shibata MA, Ward JM, Devor DE, Liu ML, Green JE (1996). Progression of prostatic intraepithelial neoplasia to invasive carcinoma in C3(1)/SV40 large T antigen transgenic mice: Histopathological and molecular biological alterations. Cancer Res 56: 4894-4903.
14. Suwa T., Nyska A., Haseman JK, Mahler JF, Maronpot RR (2002). Spontaneous lesions in control B6C3F1 mice and recommended sectioning of male accessory sex organs. Toxicol Pathol 30: 228-234.
15. US Department of Health and Human Services (1996). Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington DC.
16. Wechter WJ, Leipold DD, Murray ED Jnr., Quiggle D., McCracken JD, Barrios RS, Greenberg NM (2000). E-7869 (R-Flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse. Cancer Res 60: 2203-2208.
17. Weindruch R. (1996). The retardation of aging by caloric restriction: Studies in rodents and primates. Toxicol Pathol 24: 742-745.
18. Whiteley LO, Anver MR, Botts S., Jokinen MP (1996). Proliferative lesions ofthe intestine, salivary glands, oral cavity, and esophagus in rats. In: Guides for Toxicologic Pathology. STP/ARP/AFIP, Washington, DC.